000			02718nam a22003737a 4500
008			210719s20212021 xxu||||| |||| 00| 0 eng d
022			_a2398-8835
024			_a10.1002/hsr2.293 [doi]
024			_aHSR2293 [pii]
024			_aPMC8177896 [pmc]
040			_aOvid MEDLINE(R)
099			_a34136656
245			_aCharacteristics and treatment of elemental mercury intoxication: A case series.
251			_aHealth Science Reports. 4(2):e293, 2021 Jun.
252			_aHealth Sci Rep. 4(2):e293, 2021 Jun.
253			_aHealth science reports
260			_c2021
260			_fFY2021
260			_p2021 Jun
265			_sepublish
266			_d2021-07-19
520			_aBackground and aims: Elemental mercury toxicity is a rare condition which can be difficult to diagnose due to its nonspecific signs and symptoms. The purpose of this investigation is to describe the presenting characteristics and treatment of adult and pediatric patients with elemental mercury poisoning.
520			_aConclusion: The evaluation and treatment of patients with suspected elemental mercury poisoning frequently require a multidisciplinary approach including medical toxicologists and public health officials. A heightened awareness of the clinical presentations of this condition, as well as early identification and removal of patients from the source of exposure and consideration of chelation therapy, can result in accelerated patient recovery. Copyright (c) 2021 The Authors. Health Science Reports published by Wiley Periodicals LLC.
520			_aMethods: A retrospective review was performed in six patients with elemental mercury exposure or intoxication who were treated in an outpatient medical toxicology clinic. Clinical signs and symptoms, laboratory assessments, and public health responses were reviewed.
520			_aResults: Headache, anorexia, rash, and personality changes were commonly reported symptoms in pediatric patients; the adult patients were asymptomatic or reported signs and symptoms included myalgias, tremors, and hypertension. Delays in diagnosis were common. Symptomatic patients had 24-hour urine mercury concentrations greater than 20 mcg/L. Treatment, including removal from the exposure source as well as chelation with dimercaptosuccinic acid, resulted in resolution of signs and symptoms within 6 months of diagnosis.
546			_aEnglish
650			_aIN PROCESS -- NOT YET INDEXED
651			_aMedStar Health Research Institute
657			_aJournal Article
700			_aTefera, Eshetu
790			_aFarrell J Jr, Johnson-Arbor K, Tefera E
856			_uhttps://dx.doi.org/10.1002/hsr2.293 _zhttps://dx.doi.org/10.1002/hsr2.293
942			_cART _dArticle
999			_c6644 _d6644